MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Medullary Thyroid Cancer (MTC) is a rare endocrine malignancy.
• The role of microRNAs (miRNAs) in cancer development is increasingly recognized.
• miR-375 has been implicated in various cancers, but its specific mechanism in MTC requires elucidation.

Purpose of the Study:

• To investigate the prospective molecular mechanism of miR-375 in Medullary Thyroid Cancer (MTC).
• To identify target genes and pathways regulated by miR-375 in MTC.

Main Methods:

• Microarray data analysis from Gene Expression Omnibus (GEO) to assess miR-375 expression.
• Identification of putative miR-375 target genes using GEO datasets and 12 online prediction databases.
• In silico analyses including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and Protein-Protein Interaction (PPI) network construction.
• Validation using The Cancer Genome Atlas (TCGA) and The Human Protein Atlas (THPA) data.

Main Results:

• miR-375 expression was confirmed to be upregulated in MTC.
• 1132 prospective target genes of miR-375 were identified.
• GO analysis highlighted negative regulation of transcription and protein binding.
• KEGG analysis revealed the PI3K/Akt signaling pathway as significantly enriched, with JAK2 and NGFR showing downregulation at both mRNA and protein levels.

Conclusions:

• Upregulated miR-375 may play a crucial role in MTC tumorigenesis.
• The PI3K/Akt pathway is a key target pathway for miR-375 in MTC.
• Further investigation is necessary to fully understand the molecular mechanisms of miR-375 in MTC.